Hindustan Abdul Ahad, Haranath Chinthaginjala, Abdalrahman Mohammed Salih Karar, Musab Idris Mohammed Ali Saeed, Aladin Khalaf Alla Elhaj Eltahir Alawad
Hindustan Abdul Ahad*, Haranath Chinthaginjala, Abdalrahman Mohammed Salih Karar, Musab Idris Mohammed Ali Saeed, Aladin Khalaf Alla Elhaj Eltahir Alawad
Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research (RIPER) - Autonomous, Ananthapuramu – 515721, AP, India.
Volume - 13,
Issue - 4,
Year - 2021
The authors aimed to extend the discharge of Sirolimus from the tablets with a blend of herbal and synthetic polymers. In this study, Sirolimus was taken as a model drug, Hydroxy Propyl Methyl Cellulose as a synthetic polymer and mucilage from Hibiscus rosa sinensis leaves as a natural polymer. Sirolimus is an orphan drug used to treat Lymphangioleiomyomatosis damage and to suppress body refuse towards the transplanted organs. Sirolimus matrix tablets made with the blend of Hibiscus rosa sinensis leaves mucilage and Hydroxy Propyl Methyl Cellulose. The blend was assessed for flow possessions and the designed tablets were categorized for official and non-official tests including Sirolimus discharge. The Sirolimus matrix tablets possess good Sirolimus content with passible pre and post-formulation parameters. The study concludes that there were no chemical interactions between Sirolimus with polymers used. The study also revealed that Hibiscus rosa sinensis leaves mucilage can be a good polymer in grouping with other polymers for prolonged drug discharge.
Cite this article:
Hindustan Abdul Ahad, Haranath Chinthaginjala, Abdalrahman Mohammed Salih Karar, Musab Idris Mohammed Ali Saeed, Aladin Khalaf Alla Elhaj Eltahir Alawad. Effective Management of Rare Lymphangioleiomyomatosis Using Sirolimus: Tablet Matrix with Hibiscus rosa sinensis Leave Mucilage. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(4):276-0. doi: 10.52711/0975-4377.2021.00045
Hindustan Abdul Ahad, Haranath Chinthaginjala, Abdalrahman Mohammed Salih Karar, Musab Idris Mohammed Ali Saeed, Aladin Khalaf Alla Elhaj Eltahir Alawad. Effective Management of Rare Lymphangioleiomyomatosis Using Sirolimus: Tablet Matrix with Hibiscus rosa sinensis Leave Mucilage. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(4):276-0. doi: 10.52711/0975-4377.2021.00045 Available on: https://rjpdft.com/AbstractView.aspx?PID=2021-13-4-2
1. Wickerson LM. Oxygenation during Exercise in Individuals with Interstitial Lung Disease (Doctoral Dissertation, University of Toronto (Canada).
2. Trulock EP. Lung transplantation. American Journal of Respiratory and Critical Care Medicine. 1997 Mar;155(3):789-818.
3. Arcasoy SM, Kotloff RM. Lung transplantation. New England Journal of Medicine. 1999 Apr 8;340(14):1081-91..
4. Somani AA, Thelen K, Zheng S, Trame MN, Coboeken K, Meyer M, Schnizler K, Ince I, Willmann S, Schmidt S. Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds. British Journal of Clinical Pharmacology. 2016 Jan;81(1):137-47.
5. Ahad HA, Rajesh V, Gupta MV, Lasya DN, Harish N, Khamartaz M. Fabrication and in vitro evaluation of glimepiride hibiscus esculentus fruit mucilage sustained release matrix tablets. Int J Pharm Tech Res. 2010;2(1).
6. Ahad HA, Kumar CS, Kumar K, CGS S. Designing and evaluation of Diclofenac sodium sustained release matrix tablets using Hibiscus Rosa-Sinensis leaves mucilage. Int J of Pharm Sci Rev and Res. 2010;1(2):29-31.
7. Debunne A, Vervaet C, Mangelings D, Remon JP. Compaction of enteric-coated pellets: influence of formulation and process parameters on tablet properties and in vivo evaluation. European Journal of Pharmaceutical Sciences. 2004 Jul 1;22(4):305-14.
8. Ahad HA, Haranath C, Vikas SS, Varam NJ, Ksheerasagare T, Gorantla SP. A review on enzyme activated drug delivery system. Research Journal of Pharmacy and Technology. 2021;14(1):516-22.
9. Saifullah M, Yusof YA, Chin NL, Aziz MG. Physicochemical and flow properties of fruit powder and their effect on the dissolution of fast dissolving fruit powder tablets. Powder Technology. 2016 Nov 1;301:396-404.
10. Sun CC. Setting the bar for powder flow properties in successful high speed tableting. Powder technology. 2010 Jul 12;201(1):106-8.
11. Merchant HA, Shoaib HM, Tazeen J, Yousuf RI. Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note. AAPS Pharmscitech. 2006 Sep;7(3):E178-83.
12. Hourcade JP, Williams SR, Miller EA, Huebner KE, Liang LJ. Evaluation of tablet apps to encourage social interaction in children with autism spectrum disorders. InProceedings of the SIGCHI Conference on Human Factors in Computing Systems 2013 Apr 27 (pp. 3197-3206).
13. Bedair TM, Yu SJ, Im SG, Park BJ, Joung YK, Han DK. Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent. Journal of Colloid and Interface Science. 2015 Dec 15;460:189-99.
14. Islambulchilar Z, Ghanbarzadeh S, Emami S, Valizadeh H, Zakeri-Milani P. Development and validation of an HPLC method for the analysis of sirolimus in drug products. Advanced Pharmaceutical Bulletin. 2012 Dec;2(2):135.
15. Chen T, Liu L, Zhang L, Lu T, Matos RL, Jiang C, Lin Y, Yuan T, Ma Z, He H, Zhuang X. Optimization of the supercritical fluidized bed process for sirolimus coating and drug release. International Journal of Pharmaceutics. 2020 Nov 15;589:119809.
16. Balss KM, Llanos G, Papandreou G, Maryanoff CA. Quantitative spatial distribution of sirolimus and polymers in drug‐eluting stents using confocal Raman microscopy. Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials. 2008 Apr; 85(1):258-70.